Matches in Nanopublications for { ?s ?p "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP28388.RA9KvgMetDZwTDSDa1FvwBbJSvZ6TKpSpBP1fbfGT8xMw130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28388.RA9KvgMetDZwTDSDa1FvwBbJSvZ6TKpSpBP1fbfGT8xMw130_provenance.
- NP28396.RA8w4DyFm-KyizP7x9pQHT-T3VXyUKuSs_eVa758y4rUo130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28396.RA8w4DyFm-KyizP7x9pQHT-T3VXyUKuSs_eVa758y4rUo130_provenance.
- NP28367.RAWKTaAoplkBfO6hm5cOhDu1E5buVWVG1WsB4M-Mszjx8130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28367.RAWKTaAoplkBfO6hm5cOhDu1E5buVWVG1WsB4M-Mszjx8130_provenance.
- assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP669646.RARw59cDBgYUJpSQ3EnBKMVYaEJkZ9gHTpgnzi6NJ15_g130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669646.RARw59cDBgYUJpSQ3EnBKMVYaEJkZ9gHTpgnzi6NJ15_g130_provenance.
- NP28438.RAlShridZu9d8-3ry95vHRNAC7FoIppM3doy_Ck1Dtmo0130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28438.RAlShridZu9d8-3ry95vHRNAC7FoIppM3doy_Ck1Dtmo0130_provenance.
- assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP686022.RABZcG61gPcCCheRFBxnWuNN5jiusEvEDKttN9s6d6v9I130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686022.RABZcG61gPcCCheRFBxnWuNN5jiusEvEDKttN9s6d6v9I130_provenance.
- NP834287.RANn8A-NU1oAn_puXxzxMYaDUnpX3GwqBTDlcN_yjyPWA130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834287.RANn8A-NU1oAn_puXxzxMYaDUnpX3GwqBTDlcN_yjyPWA130_provenance.
- NP686021.RAPCRzJCizpg-sDVvPWHm10xcTdWbZ9q3Iw8WRIs23hCw130_assertion description "[Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clinically afforded protection against cardiac and renal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686021.RAPCRzJCizpg-sDVvPWHm10xcTdWbZ9q3Iw8WRIs23hCw130_provenance.